Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1054 | 1000 | 1142 | 1282 | 1633 | 2855 |
Fund Return | 5.4% | -0% | 14.23% | 8.64% | 10.3% | 11.06% |
Place in category | 1671 | 1663 | 1410 | 300 | 416 | 79 |
% in Category | 93 | 93 | 85 | 24 | 37 | 15 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Div incm Fd Sr Adv | 7.12B | 6.39 | 3.94 | 9.05 | ||
Manulife Div incm Fd Sr F | 7.12B | 6.89 | 5.11 | 10.28 | ||
Manulife Div incm Fd Sr T6 | 7.12B | 6.39 | 3.93 | 9.04 | ||
Manulife Div incm Fd Sr FT6 | 7.12B | 6.89 | 5.10 | 10.27 | ||
Manulife Glbl Eq Cl Sr Adv | 6.96B | 4.86 | 7.31 | 9.70 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 13.33B | 31.81 | 13.88 | - | ||
Capital Group Glbal Equity Fd F CAD | 13.33B | 14.67 | 3.92 | 11.29 | ||
Capital Group Glbal Equity Fd A CAD | 13.33B | 14.15 | 2.78 | 10.07 | ||
Capital Group Glbal Equity Fd D CAD | 13.33B | 14.51 | 3.57 | 10.80 | ||
Mawer Global Equity | 13.12B | 5.16 | 8.18 | 10.87 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Publicis Groupe | FR0000130577 | 5.73 | 97.76 | -3.30% | |
Marsh McLennan | US5717481023 | 4.78 | 208.88 | -0.30% | |
Microsoft | US5949181045 | 4.11 | 442.57 | +0.22% | |
Alimentation Couche Tard | CA01626P1484 | 4.07 | 75.90 | -3.78% | |
UnitedHealth | US91324P1021 | 3.71 | 497.12 | -0.04% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Strong Buy |
Technical Indicators | Strong Sell | BUY | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review